Vaccine News and Research

Latest Vaccine News and Research

First Edition: September 2, 2010

Today's headlines include reports about a new study examining the impact of the health overhaul on the small business workforce.

2 Sep 2010

First Phase I/II clinical trial to test MK-0752 in patients with advanced pancreatic cancer

Cancer Research UK's Drug Development Office has launched a clinical trial* to test an experimental drug in patients with advanced (Stage IV) pancreatic cancer - one of the most difficult cancers to treat.

2 Sep 2010

HIV-infected children who receive HAART require revaccination: Researchers

HIV-infected children receiving highly active antiretroviral therapy may require revaccination to maintain immunity against preventable diseases. There remains no standard or official recommendation on revaccination of children receiving HAART, an effective intervention in reducing morbidity and mortality in HIV-infected children.

2 Sep 2010

Nabi Biopharmaceuticals, Diosynth sign long-term commercial manufacturing agreement

Nabi Biopharmaceuticals announced today that it has entered into a long-term commercial manufacturing agreement with Diosynth RTP, Inc. for the manufacture of Drug Substance integral to the production of NicVAX, Nabi's innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse.

2 Sep 2010

Unitract Tuberculin syringe clears FDA 510k market clearance

Unilife Corporation, today announced that its Unitract Tuberculin (TB) Syringe has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA).

2 Sep 2010

Abbott RealTime HBV assay receives marketing approval from FDA

Abbott announced today it has received approval from the U.S. Food and Drug Administration to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus in a patient's blood. It is the first and only approved test capable of automating HBV viral load testing from sample extraction to final results.

2 Sep 2010

Neutralizing key toxin associated with Staph aureus bacteria reduces severity of skin and soft-tissue damage

Scientists from the National Institutes of Health and University of Chicago have found a promising treatment method that in laboratory mice reduces the severity of skin and soft-tissue damage caused by USA300, the leading cause of community-associated Staphylococcus aureus infections in the United States.

2 Sep 2010

Researchers find new fusion protein for E.coli bacterium vaccine development

South Dakota State University research is exploring a "fusion strategy" for making improved vaccines to protect pigs and humans against some strains of E. coli.

2 Sep 2010

U.N. Secretary-General, UNAIDS Executive Director highlight role NGOs can play in achieving MDGs

During the 63rd U.N. Department of Public Information/NGO Conference on Monday in Melbourne, Australia, U.N. Secretary-General Ban Ki-moon "call[ed] on delegates to do more to save the lives of mothers and babies," the Australian Associated Press/Sydney Morning Herald reports (Alexander/Rose, 8/30).

2 Sep 2010

Project GreenVax to acquire XDR GMP single-use production bioreactors from Xcellerex

Xcellerex, Inc. announced today that Project GreenVax has agreed to acquire XDR GMP single-use production bioreactors from Xcellerex. The systems will be deployed in a new facility currently under construction in Bryan, Texas. Project GreenVax is spearheaded by Texas Plant-Expressed Vaccine Consortium, which consists of G-Con, LLC and The Texas A&M University System. Financial terms were not disclosed.

31 Aug 2010

Medicago included in President's report that examines drugs to prevent spread of infectious diseases

Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it was included in a report of President Obama's Council of Advisors on Science and Technology entitled "Report to the President on Reengineering the Influenza Vaccine Production Enterprise to Meet the Challenges of Pandemic Influenza", which was released earlier this month. U.S. Health and Human Services Secretary Kathleen Sebelius and other public health officials held a briefing to discuss this report and the $2 billion plan to accelerate the development of drugs and vaccines to prevent the spread of infectious diseases.

31 Aug 2010

Biotage launches new Resolux line of HPLC columns optimized for peptide purification

Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, has launched a new range of HPLC columns optimized for peptide purification. The Resolux™ line was introduced during the ACS Fall 2010 National Meeting & Exposition in Boston, Massachusetts USA and will be premiered at the 31st European Peptide Symposium on September 5th in Copenhagen, Denmark.

31 Aug 2010

Ralphs Grocery Company to offer seasonal flu vaccine at $25

Ralphs Grocery Company is making it easy and affordable for customers to stay healthy by getting seasonal flu immunizations early.

31 Aug 2010

BARDA awards $27 million contract to Achaogen for antibiotic development

The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) today awarded a contract to develop an antibiotic that could be used against possibly two types of bioterrorism as well as common infections that are becoming resistant to antibiotics.

31 Aug 2010

Unilife Corporation 2010 fourth quarter revenue increases to $2.7 million

Unilife Corporation today announced preliminary financial results for the fourth quarter and fiscal year ended June 30, 2010.

31 Aug 2010

Also in Global Health News: GM mosquitoes; Iodine deficiency in Nepal; South African health workers strike; Novartis to build vaccine plant in Brazil; Population control in Niger

Malaysia is still "considering releasing" up to 3,000 mosquitoes that are genetically modified to "combat dengue fever, in a landmark field trial that has come in for criticism from environmentalists," Agence France-Presse reports. The insects are modified "so that their offspring quickly die," which researchers hope will cull the population and lessen the risk of dengue.

30 Aug 2010

Nanotherapeutics files NanoDTPA IND for treatment of radiation exposure

Nanotherapeutics, Inc., announced that it has filed an Investigational New Drug (IND) Application with the Food and Drug Administration (FDA) for NanoDTPA™ an orally administered capsule that is a less invasive treatment alternative to the FDA approved injectable Zn-DTPA (diethylenetriamine pentacetic acid). DTPA is used to remove radioactive compounds from the body to help eliminate the contamination. The NanoDTPA™ capsule is a unique orally-bioavailable fine particle formulation that allows DTPA to be absorbed into the body from the gastrointestinal tract.

30 Aug 2010

Children, teens need good health before the start of new school year, says medical director

With the back to school shopping season in full swing, it is also important to arm area children and teens with other tools they need to have a good school year- like medical exams. These are critical to good health and should take place before or shortly after the start of the new school year, and include a routine doctor's exam to confirm that all immunizations are up-to-date, a dental check-up, and a vision exam.

30 Aug 2010

Cedillo vs. Health and Human Services case highlights failure of Vaccine Injury Compensation Program

The Elizabeth Birt Center for Autism Law and Advocacy is deeply disappointed in the Court of Appeals for the Federal Circuit's decision to affirm Cedillo v. Secretary of Health and Human Services. EBCALA submitted a friend-of-the-court brief on behalf of 23 civil society organizations in January 2010 urging the Court of Appeals to reverse. In affirming the decision, the Court of Appeals failed to do justice by Michelle Cedillo and thousands of other petitioners in the Omnibus Autism Proceeding (OAP).

30 Aug 2010

Researchers find infectious disease proliferation in complex networks

A team of researchers led by Dr. Hern-n Makse, professor of physics at The City College of New York (CCNY), has shed new light on the way that information and infectious diseases proliferate across complex networks.

30 Aug 2010

Vaccine News and Research

Latest Vaccine News and Research

First Edition: September 2, 2010

First Phase I/II clinical trial to test MK-0752 in patients with advanced pancreatic cancer

HIV-infected children who receive HAART require revaccination: Researchers

Nabi Biopharmaceuticals, Diosynth sign long-term commercial manufacturing agreement

Unitract Tuberculin syringe clears FDA 510k market clearance

Abbott RealTime HBV assay receives marketing approval from FDA

Neutralizing key toxin associated with Staph aureus bacteria reduces severity of skin and soft-tissue damage

Researchers find new fusion protein for E.coli bacterium vaccine development

U.N. Secretary-General, UNAIDS Executive Director highlight role NGOs can play in achieving MDGs

Project GreenVax to acquire XDR GMP single-use production bioreactors from Xcellerex

Medicago included in President's report that examines drugs to prevent spread of infectious diseases

Biotage launches new Resolux line of HPLC columns optimized for peptide purification

Ralphs Grocery Company to offer seasonal flu vaccine at $25

BARDA awards $27 million contract to Achaogen for antibiotic development

Unilife Corporation 2010 fourth quarter revenue increases to $2.7 million

Also in Global Health News: GM mosquitoes; Iodine deficiency in Nepal; South African health workers strike; Novartis to build vaccine plant in Brazil; Population control in Niger

Nanotherapeutics files NanoDTPA IND for treatment of radiation exposure

Children, teens need good health before the start of new school year, says medical director

Cedillo vs. Health and Human Services case highlights failure of Vaccine Injury Compensation Program

Researchers find infectious disease proliferation in complex networks

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in